{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:20:44Z","timestamp":1793060444372,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T00:00:00Z","timestamp":1486684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s40261-017-0499-y","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T21:35:06Z","timestamp":1486676106000},"page":"503-509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions"],"prefix":"10.1007","volume":"37","author":[{"given":"Ulrike","family":"H\u00f6velmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Heise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Nosek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Sassenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Margrete Due","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Haahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,10]]},"reference":[{"key":"499_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1753-0407.2010.00077.x","volume":"2","author":"C Coninck De","year":"2010","unstructured":"De Coninck C, Frid A, Gaspar R, et al. Results and analysis of the 2008\u20132009 Insulin Injection Technique Questionnaire survey. J Diabetes. 2010;2:168\u201379.","journal-title":"J Diabetes"},{"key":"499_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.mayocp.2016.06.010","volume":"91","author":"AH Frid","year":"2016","unstructured":"Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91:1231\u201355.","journal-title":"Mayo Clin Proc."},{"key":"499_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2337\/diacare.5.2.77","volume":"5","author":"M Berger","year":"1982","unstructured":"Berger M, C\u00fcppers HJ, Hegner H, J\u00f6rgens V, Berchtold P. Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care. 1982;5:77\u201391.","journal-title":"Diabetes Care"},{"key":"499_CR4","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.2337\/diacare.16.12.1592","volume":"16","author":"JP Bantle","year":"1993","unstructured":"Bantle JP, Neal L, Frankamp LM. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects. Diabetes Care. 1993;16:1592\u20137.","journal-title":"Diabetes Care"},{"key":"499_CR5","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.2337\/diacare.19.12.1437","volume":"19","author":"EW Braak ter","year":"1996","unstructured":"ter Braak EW, Woodworth JR, Bianchi R, et al. Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin. Diabetes Care. 1996;19:1437\u201340.","journal-title":"Diabetes Care"},{"key":"499_CR6","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2337\/diacare.22.9.1501","volume":"22","author":"SR Mudaliar","year":"1999","unstructured":"Mudaliar SR, Lindberg FA, Joyce M, et al. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care. 1999;22:1501\u20136.","journal-title":"Diabetes Care"},{"key":"499_CR7","unstructured":"Apidra (insulin glulisine). CHMP Assessment Report. Procedure No. EMEA\/H\/C\/557\/X\/0023. 12 January 2010. Available from: \n                        http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/000557\/WC500090084.pdf\n                        \n                    . Accessed 19 Jan 2017."},{"key":"499_CR8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/dom.12468","volume":"17","author":"T Heise","year":"2015","unstructured":"Heise T, H\u00f6velmann U, Br\u00f8ndsted L, Adrian CL, Nosek L, Haahr H. Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart. Diabetes Obes Metab. 2015;17:682\u20138.","journal-title":"Diabetes Obes Metab."},{"key":"499_CR9","doi-asserted-by":"publisher","unstructured":"Heise T, Stender-Petersen K, H\u00f6velmann U, et al. Pharmacokinetic and pharmacodynamic properties of faster-acting insulin aspart versus insulin aspart across a clinically relevant dose range in subjects with type 1 diabetes mellitus. Clinical Pharmacokinet. 2016. doi:\n                        10.1007\/s40262-016-0473-5\n                        \n                    .","DOI":"10.1007\/s40262-016-0473-5"},{"key":"499_CR10","doi-asserted-by":"publisher","unstructured":"Heise T, Pieber TR, Danne T, Erichsen L, Haahr H. A pooled analysis of clinical pharmacology trials investigating the pharmacokinetic and pharmacodynamic characteristics of fast-acting insulin aspart in adults with type 1 diabetes. Clinical Pharmacokinet. 2017. doi:\n                        10.1007\/s40262-017-0514-8\n                        \n                    .","DOI":"10.1007\/s40262-017-0514-8"},{"key":"499_CR11","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use. Guideline on the Investigation of Bioequivalence. CPMP\/EWP\/QWP\/1401\/98 Rev. 1\/Corr. 20 January 2010. Available from: \n                        http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2010\/01\/WC500070039.pdf\n                        \n                    . Accessed 19 Jan 2017."},{"key":"499_CR12","unstructured":"Food and Drug Administration. Code of Federal Regulations. 21 CFR Part 320. Bioavailability and Bioequivalence Requirements. Available from: \n                        http:\/\/www.ecfr.gov\/cgi-bin\/text-idx?SID=b77b9e6e4aea3cdbd753c6bbd1b98077&mc=true&node=pt21.5.320&rgn=div5\n                        \n                    . Accessed 19 Jan 2017."},{"key":"499_CR13","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use. Guideline on Bioanalytical Method Validation. EMEA\/CHMP\/EWP\/192217\/2009 Rev. 1 Corr. 2. 21 July 2011. Available from: \n                        http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdf\n                        \n                    . Accessed 19 Jan 2017."},{"key":"499_CR14","unstructured":"Food and Drug Administration. Center for Drug Evaluation and Research. Center for Veterinary Medicine. Guidance for Industry. Bioanalytical Method Validation. May 2001. Available from: \n                        http:\/\/www.fda.gov\/downloads\/Drugs\/Guidance\/ucm070107.pdf\n                        \n                    . Accessed 19 Jan 2017."},{"key":"499_CR15","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2337\/diacare.28.5.1245","volume":"28","author":"American Diabetes Association","year":"2005","unstructured":"American Diabetes Association. Defining and reporting hypoglycaemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycaemia. Diabetes Care. 2005;28:1245\u20139.","journal-title":"Diabetes Care"},{"key":"499_CR16","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.2337\/diacare.15.11.1484","volume":"15","author":"JP Vora","year":"1992","unstructured":"Vora JP, Burch A, Peters JR, Owens DR. Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry. Diabetes Care. 1992;15:1484\u201393.","journal-title":"Diabetes Care"},{"key":"499_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/jps.23355","volume":"102","author":"L Jain","year":"2013","unstructured":"Jain L, Parks MH, Sahajwalla C. Determination of time to onset and rate of action of insulin products: importance and new approaches. J Pharm Sci. 2013;102:271\u20139.","journal-title":"J Pharm Sci."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0499-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-017-0499-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0499-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,16]],"date-time":"2017-04-16T23:34:34Z","timestamp":1492385674000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-017-0499-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,10]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["499"],"URL":"https:\/\/doi.org\/10.1007\/s40261-017-0499-y","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,10]]}}}